CLEARARC CAPITAL INC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 927 filers reported holding BAXTER INTL INC in Q4 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
CLEARARC CAPITAL INC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q4 2019$456,000
-32.3%
5,448
-29.3%
0.18%
-8.7%
Q3 2019$674,000
+15.8%
7,702
+8.3%
0.20%
+13.4%
Q2 2019$582,000
-10.2%
7,111
-10.8%
0.17%
-1.1%
Q1 2019$648,000
+15.9%
7,971
-6.1%
0.17%
+4.2%
Q4 2018$559,000
-43.6%
8,491
-33.9%
0.17%
+28.5%
Q3 2018$991,000
-1.0%
12,852
-5.2%
0.13%
-7.8%
Q2 2018$1,001,000
+15.6%
13,558
+1.8%
0.14%
+7.6%
Q1 2018$866,000
+5.1%
13,312
+4.5%
0.13%
+17.0%
Q4 2017$824,000
+15.4%
12,742
+11.9%
0.11%
+4.7%
Q3 2017$714,000
+6.7%
11,386
+3.1%
0.11%
-0.9%
Q2 2017$669,000
+17.4%
11,043
+0.4%
0.11%
+13.7%
Q1 2017$570,000
+17.0%
10,995
+0.1%
0.10%
+9.2%
Q4 2016$487,000
-7.9%
10,983
-1.2%
0.09%
-13.0%
Q3 2016$529,000
-6.7%
11,119
-11.3%
0.10%
-9.1%
Q2 2016$567,000
+11.2%
12,530
+1.0%
0.11%
+1.9%
Q1 2016$510,000
+7.8%
12,410
+0.1%
0.11%
+9.1%
Q4 2015$473,000
+17.4%
12,393
+1.1%
0.10%
+17.9%
Q3 2015$403,000
-53.7%
12,257
-1.5%
0.08%
-47.2%
Q2 2015$871,000
+15.7%
12,449
+13.3%
0.16%
+3.2%
Q1 2015$753,000
-5.0%
10,991
+1.6%
0.15%
-4.9%
Q4 2014$793,000
-7.6%
10,816
-9.5%
0.16%
-16.5%
Q3 2014$858,000
+0.9%
11,950
+1.6%
0.19%
-1.0%
Q2 2014$850,000
-16.2%
11,763
-14.6%
0.20%
-21.9%
Q1 2014$1,014,000
+19.9%
13,780
+13.3%
0.25%
+14.6%
Q4 2013$846,000
-5.5%
12,161
-10.7%
0.22%
-12.4%
Q3 2013$895,000
+12.0%
13,617
+18.1%
0.25%
+16.8%
Q2 2013$799,00011,5300.21%
Other shareholders
BAXTER INTL INC shareholders Q4 2016
NameSharesValueWeighting ↓
Tavio Capital LLC 68,405$5,890,0007.81%
Iron Triangle Partners LP 330,000$28,413,0007.16%
Veritas Asset Management LLP 8,942,428$769,943,0005.64%
TSFG, LLC 93,405$8,042,0005.31%
GENERATION INVESTMENT MANAGEMENT LLP 10,606,094$913,185,0005.27%
Third Point 4,000,000$344,400,0004.72%
Avidity Partners Management LP 800,900$68,957,0004.42%
Palmer Knight Co 62,275$5,362,0004.17%
Eos Focused Equity Management, L.P. 36,786$3,167,0003.70%
Dundas Partners LLP 196,133$16,887,0003.69%
View complete list of BAXTER INTL INC shareholders